In a head-to-head open-label trial reported in February 2026, average weight loss at 84 weeks favored tirzepatide, and the sponsor noted CagriSema did not meet its prespecified non-inferiority target against tirzepatide
The risk factors include either of the following: The risk factors include either of the following: body mass index (BMI) above 30 the previous baby weighed 4.5kg and more at birth one of your parents or siblings has diabetes your origin is South Asian, Black, African-Caribbean, or Middle Eastern How to manage this condition
Both in vitro and in vivo studies have evaluated the effects of flavokavains, kavalactones and/or kava extracts in different cancer models, showing the induction of apoptosis, cell cycle arrest and other antiproliferative effects in several types of cancer, including breast, prostate, bladder, and lung
Quick Answer: When Is the Best Time to Take Berberine
Semin Pediatr